Stock Events

Stock Events

Biocryst Pharmaceuticals (BCRX) Q3 2024 Earnings

5AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.31

-0.23

-0.14

-0.06

Details

Expected EPS

-0.173

Actual EPS

-0.06

Surprise EPS

0.11

Surprise Percent

+65.32%

Description

Biocryst Pharmaceuticals (BCRX) has reported earnings of -0.06 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.